The United States on Wednesday crossed an ominous new threshold of more than 3,250 lives lost to COVID-19 in a single day while public health officials stepped up preparations for a vaccine campaign of historic scope ahead of final regulatory review. In a sign that approval could be swift, documents released by the FDA ahead of the advisory review raised no new red flags over the safety or efficacy of the Pfizer vaccine. Britain became the first Western nation to begin mass inoculations with the Pfizer vaccine on Tuesday. Canada on Wednesday approved the same vaccine after an accelerated review process. Still, a sizable percentage of the U.S. population has expressed skepticism about getting a COVID-19 vaccine, creating an additional challenge.

Source: Standard Digital December 10, 2020 04:18 UTC